BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2742686)

  • 1. Management of preterm infants receiving surfactant supplementation.
    Bevilacqua G; Gaioni L; Parmigiani S
    Eur Respir J Suppl; 1989 Mar; 3():87s-90s. PubMed ID: 2742686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.
    Heldt GP; Pesonen E; Merritt TA; Elias W; Sahn DJ
    Pediatr Res; 1989 Mar; 25(3):305-10. PubMed ID: 2649864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human surfactant in the treatment of respiratory distress syndrome. A spectrum of clinical responses.
    Hallman M; Pohjavuori M; Järvenpää AL; Bry K; Merritt TA; Pesonen E
    Eur Respir J Suppl; 1989 Mar; 3():77S-80S. PubMed ID: 2663000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late surfactant treatment in preterm triplets.
    Park YI; Delmore P; Bloom BT
    Kans Med; 1989 Dec; 90(12):335-6. PubMed ID: 2635234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of symptomatic patent ductus arteriosus with ethamsylate in babies treated with exogenous surfactant.
    Amato M; Hüppi P; Markus D
    J Perinatol; 1993; 13(1):2-7. PubMed ID: 8445442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of surfactant treatment on gas-exchange and clinical course in near-term newborns with RDS.
    Golombek SG; Truog WE
    J Perinat Med; 2000; 28(6):436-42. PubMed ID: 11155428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
    Jobe A
    Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.
    Segerer H; Stevens P; Schadow B; Maier R; Kattner E; Schwarz H; Curstedt T; Robertson B; Obladen M
    Pediatr Res; 1991 Dec; 30(6):591-6. PubMed ID: 1805156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment.
    de Winter JP; Merth IT; van Bel F; Egberts J; Brand R; Quanjer PH
    Pediatr Res; 1994 May; 35(5):541-9. PubMed ID: 8065835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal lung function in very immature infants with and without RDS.
    Kavvadia V; Greenough A; Itakura Y; Dimitriou G
    J Perinat Med; 1999; 27(5):382-7. PubMed ID: 10642959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory distress syndrome treated with human surfactant: radiographic findings.
    Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
    Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S; Raju TN; Bhat R; Maeta H; Vidyasagar D
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome.
    Bunt JE; Carnielli VP; Janssen DJ; Wattimena JL; Hop WC; Sauer PJ; Zimmermann LJ
    Crit Care Med; 2000 Oct; 28(10):3383-8. PubMed ID: 11057790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.
    Seppänen MP; Kääpä PO; Kero PO; Saraste M
    Pediatrics; 1994 May; 93(5):769-73. PubMed ID: 8165076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant treatment in the neonate with severe respiratory distress syndrome.
    Horpaopan S; Sangtaveesin V; Ratrisawasdi V
    J Med Assoc Thai; 1996 Apr; 79(4):222-8. PubMed ID: 8708507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in dead space/tidal volume ratio and pulmonary mechanics after surfactant replacement therapy in respiratory distress syndrome of the newborn infants.
    Chung EH; Ko SY; Kim IY; Chang YS; Park WS
    J Korean Med Sci; 2001 Feb; 16(1):51-6. PubMed ID: 11289401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.